Chimerix Stock (NASDAQ: CMRX) stock price, news, charts, stock research, profile.
Open | $0.910 |
Close | $0.932 |
Volume / Avg. | 0 / 422.943K |
Day Range | 0.892 - 0.940 |
52 Wk Range | 0.880 - 1.570 |
Market Cap | $83.545M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 1.46% |
Days to Cover | 2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Chimerix (NASDAQ: CMRX) through any online brokerage.
Other companies in Chimerix’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Connect Biopharma Hldgs (NASDAQ:CNTB), Burning Rock Biotech (NASDAQ:BNR) and Armata Pharmaceuticals (AMEX:ARMP).
The latest price target for Chimerix (NASDAQ: CMRX) was reported by HC Wainwright & Co. on Friday, March 1, 2024. The analyst firm set a price target for 11.00 expecting CMRX to rise to within 12 months (a possible 1074.59% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Chimerix (NASDAQ: CMRX) is $0.9365 last updated April 18, 2024 at 8:23 AM EDT.
There are no upcoming dividends for Chimerix.
Chimerix’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Chimerix.
Chimerix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.